Tizanidine Tablets, USP, 4 mg, 100 Tablets (10 tablets x 10 unit dose blister packs) per carton, ...

FDA Recall #D-0892-2023 — Class II — June 23, 2023

Recall #D-0892-2023 Date: June 23, 2023 Classification: Class II Status: Terminated

Product Description

Tizanidine Tablets, USP, 4 mg, 100 Tablets (10 tablets x 10 unit dose blister packs) per carton, Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 68084-645-01 (carton), barcode (01) 003 68084 645 11 2.

Reason for Recall

Failed Dissolution Specifications: this repackaged product was recalled by the manufacturer, Dr. Reddy's Laboratories, Inc., due to out of specification results for dissolution.

Recalling Firm

Amerisource Health Services LLC — Columbus, OH

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

4,971 cartons

Distribution

Nationwide in the USA

Code Information

Lot 1004835, Exp 7/31/2023

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated